Marshall Wace’s Genprex GNPX Stock Holding History

Marshall Wace’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$158K	–	2795
2021 Q1	$158K	Buy	+1	New	+$220K	﹤0.01%	2307

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Marshall Wace's GNPX Position: Q2 2021 in Review

Marshall Wace sold out of Genprex (GNPX) in Q2 2021, closing a stake of 1 share — an estimated $158K sold.

Marshall Wace first reported a position in GNPX in Q1 2021 and held it in 1 quarter. The position peaked at $158K in Q1 2021. 32 funds tracked by Wall St. Rank hold GNPX as of Q2 2021.

Marshall Wace reported no remaining Genprex position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 1 Genprex share in Q2 2021, an estimated $158K.
Marshall Wace first reported a position in Genprex in Q1 2021 and held it in 1 quarter.
Marshall Wace's Genprex position peaked at $158K in Q1 2021.
32 funds tracked by Wall St. Rank held Genprex as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.